Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
No unit calculations
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
Available at: 24 KendalA
Commercial Availability: In the U.S., after FDA approval for women, Vyleesi was marketed by AMAG Pharmaceuticals initially, then rights were transferred
they are complementary tools for different biological objectives
Regulated degradation of HMG CoA reductase requires conformational changes in sterol-sensing domain
An end-of-Phase 2 FDA meeting is planned for Q2 2026, with Phase 3 to start in the second half of the year
US$ 21.87
US$ 28.87
US$ 21.77
US$ 27.40
US$ 27.30
00126-9/asset/467181b4-fe5d-444d-94f5-20502414ec38/main.assets/gr3.jpg)
US$ 28.04
US$ 25.75
US$ 20.02
